Inmune Bio, Inc. — Director's Dealing 2020

Jan 9, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-11-19

Reporting Person: ALLEN MARCIA (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3.91	2029-11-25	Common Stock (108000)		Direct

Footnotes

F1: Represent an initial award of options in consideration for the Reporting Person's service to the Board of Directors of INmune Bio, Inc. The options shall vest one-third on the first anniversary of the date of grant and pro rata on a monthly basis thereafter, such that the option shall be fully vested on the three-year anniversary of the date of grant.